Press release
Global Lewy Body Dementia Treatment Market Comprehensive Study: Forecasted Market Size And Growth Rate | Mallinckrodt Pharmaceuticals Co., BioArctic AB, Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals Inc.
Lewy Body Dementia Treatment Market Characteristics
The Business Research Company offers in-depth market insights through Lewy Body Dementia Treatment Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The lewy body dementia treatment market size has grown strongly in recent years. It will grow from $4.14 billion in 2023 to $4.41 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to supportive care and family education, regulatory approvals and guideline, multidisciplinary care approaches, psychosocial and behavioral interventions, multidisciplinary care approaches..
The lewy body dementia treatment market size is expected to see strong growth in the next few years. It will grow to $5.68 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to advancements in neurology, focused research initiatives, precision medicine and biomarkers, collaborative healthcare models, telemedicine expansion.. Major trends in the forecast period include family and caregiver support, integrated care models, personalized treatment approaches, non-pharmacological interventions, digital health solutions..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=9387&type=smp
Market Segmentation:
The lewy body dementia treatment market covered in this report is segmented -
1) By Drug Type: Antidepressants, Antipsychotic Drugs, Benzodiazepine, Carbidopa-Levodopa, Cholinesterase inhibitors, Modafinil
2) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
3) By Application: Alzheimer's disease, Dementia, Parkinson's disease
Major Driver - Surging Brain Disorder Prevalence Fuels Lewy Body Dementia Treatment Market
The rising prevalence of brain-related disorders is expected to propel the growth of the lewy body dementia treatment market going forward. Brain disorders refer to any disorder that impairs brain function. The impairment can be mild, moderate, or severe, depending on the extent of brain damage. Lewy body dementia treatment is used to treat brain disorders such as hallucinations, confusion, and drowsiness by increasing brain chemicals to improve alertness and cognition. For instance, in January 2022, according to a report shared by the American Heart Association Inc., a US-based nonprofit voluntary organization, brain disorders are expected to increase to 9.3 million in the US by 2060, and currently, this number is growing in the US. And one in every six people worldwide suffers from a brain disease. Currently, 1 billion people will suffer from brain disorders worldwide by 2021. Therefore, the rising prevalence of brain-related disorders is driving the growth of the lewy body dementia treatment market.
Competitive Landscape:
Major companies operating in the lewy body dementia treatment market report are Mallinckrodt Pharmaceuticals Co., BioArctic AB, Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals Inc., Allergan plc, Novartis International AG, Pfizer Inc., Bayer AG, Amneal Pharmaceuticals LLC., Boehringer Ingelheim International GmbH., Merck & Co. Inc., Abbott Ltd., B Braun SE, Biogen Inc., Biohaven Pharmaceutical Holding Company Ltd., BioMarin Pharmaceutical Inc., Blairex Laboratories Inc., Blink Health LLC, Blueprint Medicines Corporation, Bristol Myers Squibb Company, Calliditas Therapeutics AB, Catalyst Pharmaceuticals Inc., Chiesi USA Inc., Clovis Oncology Inc., Coherus Biosciences Inc., CooperSurgical Inc., Covis Pharmaceuticals Inc., Genzyme Corporation, GlaxoSmithKline plc, Eisai Co. Ltd., Bausch Health Companies Inc., Hisamitsu Pharmaceutical Co. Inc., Lundbeck Inc. .
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-treatment-global-market-report
Top Trend - Innovative Medicine In Lewy Body Dementia Treatment Market
Product innovation is a key trend gaining popularity in the lewy body dementia treatment market. Major companies operating in lewy body dementia treatment are focused on developing innovative solutions to strengthen their position in the market. For instance, in January 2023, Biogen Inc., a US-based multinational biotechnology company, developed its new medicine, lecanemab, which is a humanised monoclonal antibody. This medicine is used to treat Alzheimer's disease, which is part of the disease in Lewy body dementia. The main unique benefit of lecanemab is that it reduces the levels of brain amyloid. It treats the brain and clears the amyloid plaques thought to cause cognitive impairment and dementia in Alzheimer's disease.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Lewy Body Dementia Treatment Market Characteristics
3. Lewy Body Dementia Treatment Market Trends And Strategies
4. Lewy Body Dementia Treatment Market - Macro Economic Scenario
5. Lewy Body Dementia Treatment Market Size And Growth
…..
27. Lewy Body Dementia Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Lewy Body Dementia Treatment Market Comprehensive Study: Forecasted Market Size And Growth Rate | Mallinckrodt Pharmaceuticals Co., BioArctic AB, Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals Inc. here
News-ID: 3426297 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Lewy
Lewy Body Dementia (LBD) Market to Reach USD 5.12 Billion by 2034
Pune, India - December 2025 - The global Lewy Body Dementia (LBD) Market, valued at USD 2.98 billion in 2024, is projected to reach USD 5.12 billion by 2034, growing at a 5.6% CAGR (2025-2034), according to Exactitude Consultancy. Rising neurodegenerative disease prevalence, improved diagnostic imaging, and growing awareness of cognitive and behavioral symptoms are driving market expansion.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71909
Market Summary
The Lewy Body…
Lewy Body Dementia Treatment Market Trends That Will Shape the Next Decade: Insi …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Lewy Body Dementia Treatment Market Size By 2025?
The market for lewy body dementia therapies has experienced robust expansion lately, projected to increase its valuation from $4.43 billion in 2024 to $4.69 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.8%; this…
Lewy Body Dementia Market to Reach USD 9.4 Billion by 2034
Lewy Body Dementia (LBD) is the second most common form of progressive dementia after Alzheimer's disease, accounting for 10-15% of dementia cases. It is caused by the abnormal accumulation of alpha-synuclein protein (Lewy bodies) in the brain, leading to cognitive decline, visual hallucinations, fluctuating alertness, REM sleep behavior disorder, and Parkinsonism symptoms.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71909
With aging populations and rising awareness, the LBD market is…
Lewy Body Dementia Market Forecast 2025-2034: Comprehensive Analysis And Growth …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Lewy Body Dementia Market?
In recent times, the market size for Lewy body dementia has witnessed substantial growth. It is projected to increase from $1.12 billion in 2024 to $1.21 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The historic growth…
Lewy Body Dementia Treatment Market Challenges: Growth, Share, Value, Trends and …
Lewy Body Dementia Treatment Market Size And Forecast by 2031
The LBD Therapy Market is expanding rapidly, driven by increasing consumer demand, technological advancements, and industry-wide innovation. According to top market research firms, businesses in the Neurodegenerative Disorder Treatment Market are prioritizing digital transformation, product development, and data-driven decision-making to stay competitive. With rising investments in automation and efficiency, the Dementia Care Market is evolving to meet changing customer preferences.…
Lewy Body Dementia Treatment Market Focuses on Advancements in Diagnosis and The …
Global Lewy Body Dementia Treatment Market, By Drug Type (Cholinesterase Inhibitors, Antipsychotic Drugs, Antidepressants, Benzodiazepine, and Modafinil), Application Type (Parkinson's Disease and Alzheimer's Disease), Mode of Purchase (Prescription and Over the Counter), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies and Others) - Industry Trends and Forecast to 2031.
Data Bridge Market Research analyses that the Global Lewy Body Dementia Treatment Market which was USD 5.66 Billion in 2023…
